Saturday, June 13, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 218 of 1,261
  1. US 11542275

    Substituted imidazolidin-2-one derivatives as PRMT5 inhibitors

    Aurigene Discovery Technologies Limited · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  2. US 11542312

    IL-2 superagonists in combination with anti-PD-1 antibodies

    Medicenna Therapeutics Inc. · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  3. US 11542290

    Phenothiazine derivatives and uses thereof

    CAMP4 Therapeutics Corporation · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  4. US 11542261

    Substituted Imidazo[1,2-a]-pyridines as IRAK 1/4 and FLT3 inhibitors

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  5. US 11542229

    Cationic sulfonamide amino lipids and amphiphilic zwitterionic amino lipids

    The Board of Regents of the University of Texas System · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  6. US 11542226

    Polyfunctional cannabinoids

    AXIM BIOTECHNOLOGIES. INC. · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  7. US 11542238

    Pyrimidine cyclohexenyl glucocorticoid receptor modulators

    Corcept Therapeutics Incorporated · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  8. US 11541177

    Injection spring for aged prefilled syringe and auto injector

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  9. US 11541125

    Noncrushable pill formulations

    The Regents of the University of California · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  10. US 11541044

    K-Ras modulators

    The Regents of the University of California · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  11. US 11541077

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  12. US 11541045

    Methods of treating cancer with farnesyltransferase inhibitors

    Kura Oncology, Inc. · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  13. US 11542248

    Methods and compositions for inhibiting the interaction of menin with MLL proteins

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  14. US 11542317

    Anti-VEGF protein compositions and methods for producing the same

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  15. US 11541080

    Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them

    Finch Therapeutics Holdings LLC · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  16. US 11542302

    Modulators of melanocortin receptors for the treatment of depression and anxiety

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  17. US 11541032

    Composition containing sumo inhibitor and application

    CHINA PHARMACEUTICAL UNIVERSITY · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  18. US 11541086

    Compositions and methods for treating Alzheimer's disease

    Northwestern University · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  19. US 11541070

    Administration of an anti-activin-A compound to a subject

    Atara Biotherapeutics, Inc. · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  20. US 11542326

    Anti-IL-25 antibodies and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  21. US 11534488

    Use of semaphorin-4D binding molecules for modulation of blood brain barrier permeability

    VACCINEX, INC. · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted
  22. US 11535849

    Modulation of transthyretin expression

    Ionis Pharmaceuticals, Inc. · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted
  23. US 11534474

    Oral compositions for bladder regulation and uses thereof

    AYTU BIOPHARMA, INC. · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted
  24. US 11535658

    Activatable interleukin-2 polypeptides and methods of use thereof

    Werewolf Therapeutics, Inc. · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.